Kristina Mathis

Kristina started her career as a Cell and Molecular Biologist at Eurofins Lancaster Labs and joined GSK in 2018 as a Biopharm process development scientist, working at the interface of late-stage development and commercial manufacturing . In 2021, she joined the Digital and Data Analytics program within GSK, focused on building digital infrastructure that enables scientists to capture experiments with ease while focusing on the critical scientific steps – not the documentation. Her goal is to allow scientists to see digital and data as a superpower, reducing non-value adding activities, and driving us towards a world where we can use in-silico experimentation and data in combination with in vitro experimentation to accelerate innovative medicines to patients.